candesartan has been researched along with Dementia Praecox in 2 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Throughout the whole clinical course mentioned above, he was under treatment for schizophrenia with drugs including risperidone which possibly affects glucose metabolism." | 7.76 | The insulin sparing effect of telmisartan in a case of type 2 diabetes mellitus associated with schizophrenia under treatment of risperidone. ( Tsutsumi, E; Yamaguchi, K, 2010) |
| "Schizophrenia is a severe mental disorder with complex etiopathogenesis." | 5.62 | Low-dose candesartan prevents schizophrenia-like behavioral alterations in a neurodevelopmental two-hit model of schizophrenia. ( da Silva, FER; de Lucena, DF; Dos Santos Júnior, MA; Lima, CNC; Macedo, DS; Medeiros, IDS; Monte, AS; Moreira Lima Neto, AB; Teixeira, AL; Vasconcelos, GS; Vasconcelos, SMM, 2021) |
| " Throughout the whole clinical course mentioned above, he was under treatment for schizophrenia with drugs including risperidone which possibly affects glucose metabolism." | 3.76 | The insulin sparing effect of telmisartan in a case of type 2 diabetes mellitus associated with schizophrenia under treatment of risperidone. ( Tsutsumi, E; Yamaguchi, K, 2010) |
| "Schizophrenia is a severe mental disorder with complex etiopathogenesis." | 1.62 | Low-dose candesartan prevents schizophrenia-like behavioral alterations in a neurodevelopmental two-hit model of schizophrenia. ( da Silva, FER; de Lucena, DF; Dos Santos Júnior, MA; Lima, CNC; Macedo, DS; Medeiros, IDS; Monte, AS; Moreira Lima Neto, AB; Teixeira, AL; Vasconcelos, GS; Vasconcelos, SMM, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vasconcelos, GS | 1 |
| Dos Santos Júnior, MA | 1 |
| Monte, AS | 1 |
| da Silva, FER | 1 |
| Lima, CNC | 1 |
| Moreira Lima Neto, AB | 1 |
| Medeiros, IDS | 1 |
| Teixeira, AL | 1 |
| de Lucena, DF | 1 |
| Vasconcelos, SMM | 1 |
| Macedo, DS | 1 |
| Yamaguchi, K | 1 |
| Tsutsumi, E | 1 |
2 other studies available for candesartan and Dementia Praecox
| Article | Year |
|---|---|
Low-dose candesartan prevents schizophrenia-like behavioral alterations in a neurodevelopmental two-hit model of schizophrenia.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Disease Models | 2021 |
The insulin sparing effect of telmisartan in a case of type 2 diabetes mellitus associated with schizophrenia under treatment of risperidone.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Antipsychotic Agents; Benzimidazol | 2010 |